Clinical Trials Logo

Clinical Trial Summary

This study examines the use of Trypan Blue staining of the corneal endothelium in patients undergoing phacoemulsification. It is a single-center prospective, randomized individual cohort study. One eye in each patient with diabetic retinopathy will undergo phacoemulsification without Trypan Blue capsule staining (control eye) while the other eye will undergo phacoemulsification with Trypan Blue capsule staining (study eye). Both eyes will undergo intraocular lens implantation. Preoperative and four-week postoperative quantitative and qualitative morphometric endothelial cell analyses of the cornea will be performed using noncontact specular microscopy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03755752
Study type Interventional
Source Assiut University
Contact
Status Completed
Phase N/A
Start date January 1, 2018
Completion date August 31, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04977427 - Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes Phase 4
Recruiting NCT05386160 - Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy Phase 4
Not yet recruiting NCT04668703 - Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema N/A